Voices to Trials: Engaging Patients in Clinical Trial Design

To improve trial recruitment, engagement, and retention, and to increase the likelihood that trials reflect what matters most to patients, regulatory authorities increasingly point to methods for incorporating patient voice in the development of new therapeutics, specifically as part of clinical trials.

Join pharmaphorum on Tuesday 11th July at 10:00 ET / 15:00 BST / 16:00 CET for the webinar Voices to Trials: Engaging Patients in Clinical Trial Design, brought to you by Cerner Enviza, an Oracle Company, to hear about the company’s approach, and dive into a case study that successfully put the patient voice at the center of a trial design developed by Organon that was accepted by regulatory authorities.

Learn about important motivations to capture patient voices in clinical trial design that include:

• The consequence of ignoring patient priorities and experiences, which can negatively affect program development and trial execution success 
• The growing expectation by regulators that patient engagement play a meaningful role in trial design
• How listening to patient voices can help the life sciences act on patient needs in clinical trial development

Cerner Enviza presenters will share guiding principles of our qualitative exploratory approach. We will be joined by Organon, who will share their view on the importance of patient centricity to their business, development of their endometriosis-related pain trial, and relevance of capturing patient voice in the outcome of a regulatory submission process.

The webinar is intended for patient voice and patient engagement leaders, clinical directors and therapeutic leaders in the R&D industry, and teams involved in early evidence gathering.

Register today to find out more

About the panel

Jeanette Hodgson, Head of Global Qualitative Strategy, Cerner Enviza an Oracle Company
Jeanette has over 30 years experience applying qualitative methods to elicit insights from a variety of stakeholders to support brand strategy development in a commercial setting, and to generate evidence in real world and clinical settings. In this webinar, she will share methods successfully adopted to engage with patients to promote meaningful conversations and authentic feedback on clinical trial designs.

Rebecca Nash, PhD, Principal RWE, Cerner Enviza an Oracle Company
Rebecca has worked for over 25 years in research consultancy and evidence-based strategy; at Cerner Enviza she leads a team of RWE research professionals. During the webinar, drawing on her background and experience in patient engagement research principles, she will share an approach that effectively brings the patient voice to the forefront of clinical trial design.

Felipe Arbelaez, MD, MBA, Executive Director Clinical Research, Organon
Felipe has over 23 years of experience in the pharmaceutical industry and clinical research with emphasis in Phase 2 and 3 development programmes. During the webinar, he will discuss the importance of including patients’ perspective into the development of innovative medications.

Andrea Niklaus, PhD, Director Clinical Research, Organon
Andrea has a PhD with over 15 years of experience in the pharmaceutical industry in the Medical Affairs & Clinical Research space with an emphasis on pipeline programs. During her graduate studies, Andrea explored the role of sex steroids in early pregnancy and joined Organon over two years ago to re-focus her innate passion to help advance Women’s Health and contribute to the development of new medicines that can improve the quality of life for Women. During the webinar she will discuss methodologies used to bring the patients’ voice to the design of an endometriosis-related clinical trial.

Eloise McLennan, Deep Dive editor (moderator)
Eloise McLennan is the editor for pharmaphorum’s Deep Dive magazine. She has been a journalist and editor in the healthcare field for more than five years and has worked at several leading publications in the UK.